Acquisitions (Tables)

12 Months Ended

Dec. 31, 2023

Alfmeier

Business Acquisition [Line Items]

Summary of Product Revenues and Operating Income

The following table provides product revenues and operating income from Alfmeier that are included in our consolidated financial statements for the year ended December 31, 2022, following the August 1, 2022 acquisition date:

	Year Ended December 31,
	2022
Product revenues	$	98,960
Net loss		(2,675	)

Summary of Final Purchase Consideration And Estimated Fair Values Of Assets Acquired And Liabilities Assumed

The following table summarizes the final purchase consideration and estimated fair values of assets acquired and liabilities assumed as of the acquisition date:

	Initial Allocation as of August 1, 2022			Measurement Period Adjustments			Final Allocation
Purchase price, consideration, net of cash acquired	$	164,887		$	5,813		$	170,700
Accounts receivable		24,988			(121	)		24,867
Inventory		36,026			417			36,443
Prepaid expenses and other assets		20,920			(74	)		20,846
Operating lease right-of-use assets		4,608			—			4,608
Property and equipment		89,942			1,242			91,184
Other intangible assets		22,668			8,791			31,459
Goodwill		43,678			(9,707	)		33,971
Assumed liabilities		(55,994	)		975			(55,019	)
Deferred tax liabilities		(21,949	)		4,290			(17,659	)
Net assets acquired	$	164,887		$	5,813		$	170,700

Summary of Allocation of Purchase Consideration to Other Intangible Assets Acquired

The following table summarizes the allocation of the purchase consideration to the other intangible assets acquired:

	Preliminary Fair Value		Weighted Average Life (in years)
Definite-lived:
Customer related	$	19,812		14
Technology		11,647		9
Total	$	31,459

Summary of Unaudited Pro Forma Information

The following unaudited pro forma information represents our product revenues and net income as if the acquisition of Alfmeier had occurred as of January 1, 2021:

	Year Ended December 31,
	2022		2021
Product revenues	$	1,348,295	$	1,304,505
Net Income		17,645		92,079

Dacheng

Business Acquisition [Line Items]

Summary of Product Revenues and Operating Income

The results of Dacheng's operations are reported within the Medical segment from the acquisition date.

The following table provides product revenues and operating income from Dacheng that are included in our consolidated financial statements for the year ended December 31, 2022, following the July13, 2022 acquisition date:

	Year Ended December 31,
	2022
Product revenues	$	3,499
Net Loss		(217	)

Summary of Final Purchase Consideration And Estimated Fair Values Of Assets Acquired And Liabilities Assumed

The following table summarizes the final purchase consideration and estimated fair values of assets acquired and liabilities assumed as of the acquisition date:

	Initial Allocation as of July 13, 2022			Measurement Period Adjustments			Final Allocation
Purchase price, cash consideration, net of cash acquired	$	35,048		$	—		$	35,048
Accounts receivable		746			(124	)		622
Inventory		1,942			(177	)		1,765
Prepaid expenses and other assets		152			22			174
Operating lease right-of-use assets		841			—			841
Property and equipment		684			—			684
Other intangible assets		19,094			965			20,059
Goodwill		22,995			(3,464	)		19,531
Assumed liabilities		(2,799	)		(515	)		(3,314	)
Deferred tax liabilities		(8,607	)		3,293			(5,314	)
Net assets acquired	$	35,048		$	—		$	35,048

Summary of Allocation of Purchase Consideration to Other Intangible Assets Acquired

The following table summarizes the allocation of the purchase consideration to the other intangible assets acquired:

	Preliminary Fair Value		Weighted Average Life (in years)
Definite-lived:
Customer related	$	12,837		12
Technology		4,749		12
Indefinite-lived:
Tradenames		2,473		—
Total	$	20,059